Michael B. Mason - Feb 9, 2022 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
Sr. VP & Pres., Lilly Diabetes
Signature
/s/ Jonathan Groff for Michael B. Mason, pursuant to attached authorization
Stock symbol
LLY
Transactions as of
Feb 9, 2022
Transactions value $
$635,421
Form type
4
Date filed
2/11/2022, 05:19 PM
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Award $635K +2.61K +10.49% $243.27 27.5K Feb 9, 2022 Direct
holding LLY Common Stock 935 Feb 9, 2022 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Award $0 +6.69K $0.00 6.69K Feb 9, 2022 Common Stock 6.69K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.